October 18, 2026 11:10 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Internet access a fundamental right for children': SC rejects age-based 'blanket' ban | 'We will fight our own government': RG Kar victim's father threatens fresh protest after Sandip Ghosh gets bail | RG Kar shocker: Sandip Ghosh gets bail as only 7 of 147 witnesses examined, junior doctor blasts CBI | Trump waives Russia-related sanctions | 'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism

Dr Reddy's launches advanced B2B Customer Service Portal 'XCEED'

| @indiablooms | Mar 18, 2019, at 03:28 pm

Hyderabad, Mar 18 (UNI) Dr Reddy’s Laboratories Limited on Monday announced the launch of its advanced B2B Customer Service Portal “XCEED.”

Fully focused on meeting the growing demand for Dr Reddy’s portfolio of generic Active Pharmaceutical Ingredients (APIs), the customer service portal significantly increases the operational efficiency in doing business with Dr Reddy’s, a company statement here said.

The no-boundaries platform designed based on customers’ insights and feedback, is a huge step forward in providing an advanced customer experience and facilitating collaboration.

Customers are now able to manage the whole business process in real time, from ordering samples to submit and track their orders, but also to closely interact with Dr Reddy’s inter-disciplinary support team and much more. Catering to leading innovator and generic companies across the US., Europe, Latin America, Japan, Korea and other emerging markets, Dr. Reddy’s is recognized as one of the largest API suppliers.

The launch of XCEED gives now instant access to an industry leading portfolio which spans across a wide range of indications and complex molecules such as steroids, peptides or highly potent APIs (HPAPI).

The platform will be presented for the first time to customers during DCAT week in New York from March 18-21, 2019 and will be available to API customers across the globe during the next week, the statement added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.